An AAV Gene Therapy Trial of AFTX-201 in Adults With BAG3-Associated Dilated Cardiomyopathy (DCM)

计划入组 22 人 · 首次发布于 2026 年 2 月 23 日

A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy

计划入组 8 人 · 首次发布于 2025 年 8 月 22 日

Mechanisms of Hypoglycemia Associated Autonomic Dysfunction, Q.3

计划入组 22 人 · 首次发布于 2008 年 8 月 27 日

BCL2 inhibitor(ChemDiv)

Oxybenzone(Meijer)

C₁₄H₁₂O₃

BE-3-3-3-3

Associated Capital

United States

3-D Matrix Ltd.

Japan

River 3 Renal Corp.

United States

Affinia Therapeutics Partners with DCM Foundation to Advance BAG3 Dilated Cardiomyopathy Awareness and Genetic Testing

BCL2 Protein Identified as Potential Drug Target in Aggressive Prostate Cancer

Managing Toxicities in CLL Treatment: Expert Insights on BCL2 and BTK Inhibitor Selection